Methodological issues in randomized trials assessing probiotics for periodontal treatment

Journal of Periodontal Research

Volumn 47, Issue 1, 2012, Pages 15-26

  Dhingra, K ^a  

^a NSVK Sri Venkateshwara Dental College   (India)

Author keywords

Gingivitis; Periodontal diseases; Probiotics; Randomized controlled trial

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

EPIDEMIOLOGY; HUMAN; METHODOLOGY; PATIENT SAFETY; PERIODONTAL DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STANDARD; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); HUMANS; PATIENT SAFETY; PERIODONTAL DISEASES; PLACEBOS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84855357237     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01399.x     Document Type: Review

References (50)

1. Stamatova I, Meurman JH. Probiotics and periodontal disease. Periodontol 2000 2009;51:141-151.
2. Chapple ILC. Periodontal diagnosis and treatment - where does the future lie? Periodontol 2000 2009;51:9-24.
3. FAO/WHO. (2001) Health and nutritional properties of probiotics in food including powder milk with live Lactic Acid Bacteria. Report of a Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. URL: [accessed on 15 March 2011].
4. Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 2005;113:188-196.
5. Meurman JH, Stamatova I. Probiotics: contributions to oral health. Oral Dis 2007;13:443-451.
6. Teughels W, Essche MV, Sliepen I, Quirynen M. Probiotics and oral healthcare. Periodontol 2000 2008;48:111-147.
7. Bonifait L, Chandad F, Grenier D. Probiotics for oral health: myth or reality? J Can Dent Assoc 2009;75:585-590.
8. Stamatova I, Meurman JH. Probiotics: health benefits in the mouth. Am J Dent 2009;22:329-338.
9. Flichy-Fernández AJ, Alegre-Domingo T, Peñarrocha-Oltra D, Peñarrocha-Diago M. Probiotic treatment in the oral cavity: an update. Med Oral Patol Oral Cir Bucal 2010;15:e677-e680.
10. Haukioja A. Probiotics and oral health. Eur J Dent 2010;4:348-355.
11. Hoffman FA. Development of probiotics as biologic drugs. Clin Infect Dis 2008;46:S125-S127.
12. Tamayo C. Clinical research on probiotics: the interface between science and regulation. Clin Infect Dis 2008;46: S101-S103.
13. Hoffman FA, Heimbach JT, Sanders ME, Hibberd PL. Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. Clin Infect Dis 2008;46:S53-S57.
14. Rijkers GT, Bengmark S, Enck P et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 2010;140:671S-676S.
15. Joint FAO/WHO Working Group. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. 2002. URL: [accessed on 16 March 2011].
16. Teughels W, Loozen G, Quirynen M. Do probiotics offer opportunities to manipulate the periodontal oral microbiota? J Clin Periodontol 2011;38:159-177.
17. Moher D, Schulz KF, Altman DG, CONSORT group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134:657-662.
18. Higgins JPT, Altman DG. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.0.0. The Cochrane Collaboration, updated February 2008. URL: [accessed on 29 March 2011].
19. Pozharitskaia MM, Morozova LV, Melnichuk GM, Melnichuk SS. [The use of the new bacterial biopreparation Acilact in the combined treatment of periodontitis]. Stomatologia (Mosk) 1994;73:17-20. Russian.
20. Morozova LV, Pozharitskaia MM, Mel'nichuk GM. [The therapeutic efficacy of probiotics for the correction of microfloral imbalance in periodontitis]. Stomatologiia (Mosk) 1996; 68-69. Russian.
21. Grudianov AI, Dmitrieva NA, Fomenko EV. [Use of probiotics Bifidumbacterin and Acilact in tablets in therapy of periodontal inflammations]. Stomatologiia (Mosk) 2002;81:39-43. Russian.
22. Volozhin AI, Il'in VK, Maksimovskiä IUM et al. [Development and use of periodontal dressing of collagen and Lactobacillus casei 37 cell suspension in combined treatment of periodontal disease of inflammatory origin (a microbiological study)]. Stomatologiia (Mosk) 2004;83:6-8. Russian.
23. Matsuoka T, Sugano N, Takigawa S et al. Effect of oral Lactobacillus salivarius TI 2711 administration on periodontopathic bacteria in subgingival plaque. J Jpn Soc Periodontol 2006;48:315-324.
24. Zhu Y, Xiao L, Shen D, Hao Y. Competition between yogurt probiotics and periodontal pathogens in vitro. Acta Odontol Scand 2010;68:261-268.
25. Hillman JD, Shivers M. Interaction between wild-type, mutant and revertant forms of the bacterium Streptococcus sanguis and the bacterium Actinobacillus actinomycetemcomitans in vitro and in the gnotobiotic rat. Arch Oral Biol 1988;33:395-401.
26. Teughels W, Newman MG, Coucke W et al. Guiding periodontal pocket recolonization: a proof of concept. J Dent Res 2007;86:1078-1082.
27. Nackaerts O, Jacobs R, Quirynen M, Rober M, Sun Y, Teughels W. Replacement therapy for periodontitis: pilot radiographic evaluation in a dog model. J Clin Periodontol 2008;35:1048-1052.
28. Ishikawa H, Aiba Y, Nakanishi M, Oh-Hashi Y, Koga Y. Suppression of periodontal pathogenic bacteria in the saliva of human by the administration of Lactobacillus salivarius TI2711. J Jap Soc Periodontol 2003;45:105-112.
29. Riccia DND, Bizzini F, Perilli MG et al. Anti-inflammatory effects of L. brevis (DC2) on periodontal disease. Oral Dis 2007;13:376-385.
30. Zahradnik RT, Magnusson I, Walker C, Mcdonell E, Hillman CH, Hillman JD. Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash. J Appl Microbiol 2009;107:682-690.
31. Staab B, Eick S, Knofler G, Jentsch H. The influence of a probiotic milk drink on the development of gingivitis: a pilot study. J Clin Periodontol 2009;36:850-856.
32. Tsubura S, Mizunuma H, Ishikawa S et al. The effect of Bacillus subtilis mouth rinsing in patients with periodontitis. Eur J Clin Microbiol Infect Dis 2009;28:1353-1356.
33. Iwamoto T, Suzuki N, Tanabe K, Takeshita T, Hirofuji T. Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:201-208.
34. Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed Dent J 2006;30:55-60.
35. Shimauchi H, Mayanagi G, Nakaya S et al. Improvement of periodontal condition by probiotics with Lactobacillus salivarius WB21: a randomized, double-blind, placebo-controlled study. J Clin Periodontol 2008;35:897-905.
36. Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C. Short-term effect of chewing gums containing probiotic Lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontol Scand 2009;67:19-24.
37. Mayanagi G, Kimura M, Nakaya S et al. Probiotic effects of orally administered Lactobacillus salivarius WB21-containing tablets on periodontopathic bacteria: a double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol 2009;36:506-513.
38. Cioffi I, Farella M. Quality of randomised controlled trials in dentistry. Int Dent J 2011;61:37-42.
39. Hill C, LaValley M, Felson D. Discrepancy between published report and actual conduct of randomized clinical trials. J Clin Epidemiol 2002;55:783-786.
40. Huwiler-Müntener K, Jüni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002;287:2801-2804.
41. Pildal J, Chan AW, Hrobjartsson A, Forfang E, Altman DG, Gotzsche PC. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ 2005;330:1049-1052.
42. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
43. Hujoel PP. Endpoints in periodontal trials: the need for an evidence-based research approach. Periodontol 2000 2004;36:196-204.
44. Brennan DS, Spencer AJ, Roberts-Thomson KF. Quality of life and disability weights associated with periodontal disease. J Dent Res 2007;86:713-717.
45. Robertson PB, Armitage GA, Buchanan SA, Taggart EJ. The design of trials to test the efficacy of plaque control agents for periodontal diseases in humans. J Dent Res 1989;68:1667-1671.
46. Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol 2002;29:6-16.
47. Yoshinari N, Kawase H, Mitani A et al. Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1β in gingival crevicular fluid and gingival tissues. J Periodont Res 2004;39:158-167.
48. Güllü C, Ozmeric N, Tokman B, Elgün S, Balos K. Effectiveness of scaling and root planing versus modified Widman flap on nitric oxide synthase and arginase activity in patients with chronic periodontitis. J Periodont Res 2005;40:168-175.
49. Brown P, Brunnhuber K, Chalkidou K et al. How to formulate research recommendations. BMJ 2006;333:804-806.
50. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010;152:726-732.